Endocrine / GH

PT-141 10mg

10mg

PT-141 10mg is a synthetic peptide studied in controlled laboratory research involving peptide signaling and receptor activity. Supplied as a lyophilized powder and tested using HPLC and LC-MS methods, it supports research requiring consistent composition and analytical purity. For Research Use Only. Not for human or animal use. Not FDA evaluated.

Endocrine — Research Compound

COA Pre-Purchase ≥99% Purity Free Overnight > $250 Research Use Only
PT-141 10mg
Research Use Only

The following compounds operate through distinct, non-overlapping mechanisms that complement this product's research pathways. Each is independently available from the General Peptide catalog.

Selank 10mg
$31.99

Selank 10mg is a synthetic peptide studied in laboratory research focused on peptide signaling, molecular interactions, and structural behavior. Its defined composition supports controlled research into peptide stability and activity. For Resea...

Semax 10mg
$26.40

Semax 10mg is a synthetic peptide studied in laboratory research focused on signaling pathways, peptide interactions, and structural activity. Its defined composition supports controlled studies of peptide stability and behavior within experime...

NAD+ 1000mg
$59.40

NAD+ 1000mg (Nicotinamide Adenine Dinucleotide) is a coenzyme studied in laboratory research focused on cellular energy metabolism and redox processes. Its defined composition supports controlled research into electron transfer, cellular pathwa...

KPV 10mg
$37.80

KPV 10mg is a synthetic tripeptide composed of lysine, proline, and valine, supplied as a lyophilized powder for controlled laboratory research. This KPV 10mg research compound is studied in experimental models involving peptide signaling, immu...

Selank 10mg Semax 10mg NAD+ 1000mg KPV 10mg
5 compounds added to cart
All combination information is derived from published peer-reviewed scientific literature and provided for research design reference only. All compounds are for in vitro laboratory research use only.